Inflammatory intermediaries in inflammatory bowel disease.

Inflammatory intermediaries in inflammatory bowel disease.

Item
http://www.wikidata.org/entity/Q38660602
Phospholipase A2 gene expression and activity in histologically normal ileal mucosa and in Crohn's ileitis.N-3 fatty acids for the treatment of inflammatory bowel diseases.Effect of olive oil on early and late events of colon carcinogenesis in rats: modulation of arachidonic acid metabolism and local prostaglandin E(2) synthesis.Assessment of disease severity and activity in inflammatory bowel disease.Tumor necrosis factor-alpha potentiates phospholipase A2-stimulated release and metabolism of arachidonic acid in cultured intestinal epithelial cells (INT 407).Effects of endotoxin and dexamethasone on group I and II phospholipase A2 in rat ileum and stomach.Effects of dopaminergic drugs on inflammatory bowel disease induced with 2,4-dinitrofluorbenzene in BALB/c mice.5-amino-salicylate in the management of inflammatory bowel disease.The diverse actions of nicotine and different extracted fractions from tobacco smoke against hapten-induced colitis in rats.
P2860

Inflammatory intermediaries in inflammatory bowel disease.

Item
http://www.wikidata.org/entity/Q38660602
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年学术文章
@wuu
1989年学术文章
@zh-cn
1989年学术文章
@zh-hans
1989年学术文章
@zh-my
1989年学术文章
@zh-sg
1989年學術文章
@yue
1989年學術文章
@zh
1989年學術文章
@zh-hant
name
Inflammatory intermediaries in inflammatory bowel disease.
@en
type
label
Inflammatory intermediaries in inflammatory bowel disease.
@en
prefLabel
Inflammatory intermediaries in inflammatory bowel disease.
@en
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P6179
P698
P921
P356
P1433
P1476
Inflammatory intermediaries in inflammatory bowel disease.
@en
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P6179
P698
P921